Trial 9L-17-15


A phase I dose escalation study with expansion to evaluate the safety of sEPHB4-HSA in combination with cytarabine or liposomal vincristine in patients with relapsed or refractory acute leukemia

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Akil Merchant, M.D.
Other Trial Staff:  Simbiso Peresuh, Coordinator, John Lee, D.M., Suraj Chandwani, D.M., Ashot Minasyan, D.M., Anastasia Philabaum, R.N., Christine Duran, Coordinator, Donna Fernando, Coordinator, Ibrahim Meena, D.M.

Staff may log in to see study documents.







For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.